Highly targeted screening system for carbapenem antibiotics.

Area of Science:

• Microbiology
• Antibiotic Discovery
• Biotechnology

Background:

• Carbapenem antibiotics are crucial for treating multidrug-resistant bacterial infections.
• Effective screening methods are needed to discover novel carbapenem producers.
• Actinomycetes are a rich source of diverse bioactive compounds, including antibiotics.

Purpose of the Study:

• To develop an improved screening system for identifying carbapenem antibiotic producers from actinomycetes.
• To optimize isolation, cultivation, and identification methods for carbapenem discovery.

Main Methods:

• Utilized an amoxicillin/clavulanate-containing medium to increase the isolation frequency of carbapenem antibiotic producers.
• Employed agar-surface cultivation on oatmeal-yeast extract-malt extract (OMYM) medium for optimal antibiotic production.
• Developed an agar-diffusion assay using beta-lactamase susceptibility profiles for simplified carbapenem identification.

Main Results:

• The amoxicillin/clavulanate medium increased carbapenem producer isolation from 0.6% to 20%.
• OMYM medium proved most suitable for maximizing antibiotic production.
• The agar-diffusion assay effectively distinguished carbapenem antibiotics from other antibiotic classes based on beta-lactamase hydrolysis.

Conclusions:

• The developed screening system significantly enhances the efficiency of carbapenem antibiotic discovery from actinomycetes.
• The optimized methods facilitate higher isolation rates and simplified identification of carbapenem antibiotics.
• This approach holds promise for the continued search for novel carbapenem antibiotics to combat antimicrobial resistance.